Skip to main content
. Author manuscript; available in PMC: 2008 Oct 27.
Published in final edited form as: Mol Ther. 2004 Apr;9(4):519–526. doi: 10.1016/j.ymthe.2004.01.016

FIG. 4.

FIG. 4

Histomorphometric analysis of the specimens 14 days postsurgery and gene delivery. Ad-PDGF-B treatment increased cementum formation, compared to Ad-luciferase treatment (*P < 0.05). Furthermore, Ad-PDGF-B treatment not only improved the bridging length of newly formed alveolar bone compared to Ad-luciferase (**P < 0.01) and collagen matrix alone (*P < 0.05) groups, but also enhanced the percentage of alveolar bone fill compared to Ad-luciferase and Ad-PDGF-1308 treatments (*P < 0.05) (n = 6–8 specimens/group).